moxalactam has been researched along with clindamycin in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (85.71) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 2 (5.71) | 29.6817 |
| 2010's | 1 (2.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Schaadt, RD; Yagi, BH; Zurenko, GE | 1 |
| Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP | 1 |
| Heizmann, W; Luft, G; Werner, H | 1 |
| Johnson, JT; Yu, VL | 1 |
| Danziger, LH; Ferron, JL; Gauderer, MW; Gordon, N; Hau, T; Stellato, TA | 1 |
| Aldridge, KE; Faro, S; Nicaud, SK; Pastorek, JG | 1 |
| Bivins, BA; Crots, LD; Fifer, T; Horst, HM; Obeid, FN; Sorensen, VJ | 1 |
| Gibbs, RS; Goldspiel, BR; Knodel, LC | 1 |
| Defresne, N; Husson, M; Klastersky, J; Van der Auwera, P; Van Laethem, Y | 1 |
| Bourgault, AM; Horn, R; Lamothe, F | 1 |
| Duff, P | 1 |
| Caplan, ES; Fitzpatrick, BJ; Joshi, M; Tenney, JH; Warren, JW | 1 |
| Bonner, DP; Clark, JM; Fernandes, PB; Kao, CC; Sykes, RB; Weinberg, DS | 1 |
| Augenstein, D; Byers, P; Echenique, M; Gomez, GA; Kreis, DJ; Martinez, O; Plasencia, G; Vopal, JJ | 1 |
| Sabath, LD; Tack, KJ | 1 |
| Landers, DV; Ohm-Smith, M; Robbie, MO; Sweet, RL | 1 |
| Benitez, PR; Nelson, RM; Newell, MA; Wilson, RF | 1 |
| Baxter, JG; Marble, DA; Schentag, JJ; Walczak, P; Wels, PB; Whitfield, LR | 1 |
| Citron, DM; Goldstein, EJ | 1 |
| Raff, MJ; Schupp, LG; Summersgill, JT | 1 |
| Klastersky, J; Lagast, H | 1 |
| Brown, RA; Chou, S; Richards, GK | 1 |
| Herbert, DA | 1 |
| Geheber, CE; Kolb, L; Stone, HH | 1 |
| Lascola, RJ; Reitberg, DP; Schentag, JJ; Van Tyle, JH; Walczak, P; Wels, PB | 1 |
| Blanco, JD; Castaneda, YS; Duff, P; Gibbs, RS; St Clair, PJ | 1 |
| Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
| Ericsson, CD; Rowlands, BJ | 1 |
| Alvarez, S; DeMaria, A; Klein, JO; McCabe, WR | 1 |
| Tally, FP | 1 |
| Amsel, R; Eschenbach, DA; Holmes, KK; Spiegel, CA | 1 |
| Goumas, PD; Moschovakis, ED; Naxakis, SS; Papavasiliou, DA; Skoutelis, A; Tsintsos, SJ | 1 |
2 review(s) available for moxalactam and clindamycin
| Article | Year |
|---|---|
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
18 trial(s) available for moxalactam and clindamycin
| Article | Year |
|---|---|
Antibiotic use during major head and neck surgery.
Topics: Anti-Bacterial Agents; Cefazolin; Cefoperazone; Cefotaxime; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Gentamicins; Head and Neck Neoplasms; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation | 1988 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
Moxalactam versus clindamycin plus tobramycin for the treatment of puerperal infections.
Topics: Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Humans; Moxalactam; Pregnancy; Prospective Studies; Puerperal Infection; Random Allocation; Tobramycin | 1987 |
A prospective randomized comparison of a single antibiotic (moxalactam) versus combination therapy (gentamicin and clindamycin) in penetrating abdominal trauma.
Topics: Abdominal Injuries; Adolescent; Adult; Aged; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Wounds, Penetrating | 1988 |
Prospective cost analysis of moxalactam versus clindamycin plus gentamicin for endomyometritis after cesarean section.
Topics: Cesarean Section; Clindamycin; Costs and Cost Analysis; Endometritis; Female; Gentamicins; Humans; Moxalactam; Postoperative Complications | 1988 |
Comparative serum bactericidal activity against test anaerobes in volunteers receiving imipenem, clindamycin, latamoxef and metronidazole.
Topics: Adult; Bacteria, Anaerobic; Clindamycin; Female; Humans; Imipenem; Male; Metronidazole; Moxalactam; Random Allocation; Thienamycins | 1987 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
Topics: Bacterial Infections; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Tobramycin | 1986 |
A prospective randomized study of moxalactam versus gentamicin and clindamycin in penetrating abdominal trauma.
Topics: Abdominal Injuries; Adolescent; Adult; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Moxalactam; Premedication; Prospective Studies; Random Allocation; Vitamin K; Wounds, Penetrating | 1986 |
Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
Topics: Adolescent; Adult; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Middle Aged; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Random Allocation; Tobramycin | 1985 |
Single-antibiotic use for penetrating abdominal trauma.
Topics: Abdominal Injuries; Blood Coagulation; Clindamycin; Colon; Drug Therapy, Combination; Humans; Moxalactam; Postoperative Care; Premedication; Prospective Studies; Random Allocation; Tobramycin; Wound Infection; Wounds, Penetrating | 1986 |
Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.
Topics: Abdomen; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Clindamycin; Drug Combinations; Female; Hemorrhage; Humans; Infections; Male; Middle Aged; Moxalactam; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time; Random Allocation; Risk; Tobramycin; Vitamin K | 1985 |
Anaerobic infections in cancer patients--a retrospective analysis of clindamycin, tinidazole, doxycycline, cefoxitin and lamoxactam.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Cephamycins; Clindamycin; Clinical Trials as Topic; Doxycycline; Drainage; Female; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Retrospective Studies; Tinidazole | 1982 |
Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Postoperative Complications; Prospective Studies; Random Allocation | 1983 |
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.
Topics: Abdomen; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infections; Male; Middle Aged; Moxalactam; Nutrition Disorders; Prognosis; Random Allocation; Staphylococcal Infections; Staphylococcus; Tobramycin | 1983 |
A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section delivery.
Topics: Adult; Cephalosporins; Cephamycins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Hypersensitivity; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Infant, Newborn; Moxalactam; Pregnancy; Puerperal Infection; Random Allocation | 1983 |
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
Comparative studies of antibiotic therapy after penetrating abdominal trauma.
Topics: Abdominal Injuries; Adolescent; Cefoxitin; Cephalosporins; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation; Time Factors; Tobramycin; Wound Infection; Wounds, Gunshot; Wounds, Stab | 1984 |
17 other study(ies) available for moxalactam and clindamycin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The bactericidal activity and postantibiotic effect of trospectomycin.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Enterococcus faecalis; Escherichia coli; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxalactam; Neisseria gonorrhoeae; Spectinomycin; Staphylococcus epidermidis | 1992 |
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1987 |
In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefotaxime; Cefoxitin; Cephalosporins; Clindamycin; Clostridium; Moxalactam; Peptococcaceae; Propionibacterium acnes | 1988 |
Disk diffusion susceptibility testing of the Bacteroides fragilis group.
Topics: Bacteroides fragilis; Cefoxitin; Chloramphenicol; Clindamycin; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins; Ticarcillin | 1987 |
Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Bacterial Toxins; Cecum; Cefoperazone; Ceftazidime; Clindamycin; Colitis; Cricetinae; Disease Models, Animal; Drug Evaluation; Injections, Intraperitoneal; Male; Mesocricetus; Moxalactam | 1986 |
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
Topics: Amikacin; Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Salmonella; Serratia; Staphylococcus; Streptococcus; Tobramycin | 1985 |
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Topics: Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Cross Infection; Hospitals, Community; Humans; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone.
Topics: Animals; Anti-Infective Agents; Bone and Bones; Cefoxitin; Cephamycins; Chloramphenicol; Clindamycin; Metronidazole; Moxalactam; Rats; Rats, Inbred Strains; Ticarcillin; Time Factors | 1982 |
A new approach to antibiotic therapy in colon surgery based on bioassay tissue concentrations.
Topics: Animals; Anti-Bacterial Agents; Cefoxitin; Cephamycins; Clindamycin; Colon; Dogs; Enterocolitis, Pseudomembranous; Granulation Tissue; Metronidazole; Moxalactam; Premedication; Surgical Wound Infection; Tissue Distribution | 1982 |
Claims for moxalactam.
Topics: Advertising; Cephalosporins; Cephamycins; Clindamycin; Gentamicins; Humans; Moxalactam | 1982 |
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
Topics: Amikacin; Ampicillin; Carbenicillin; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Clindamycin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Haemophilus influenzae; Moxalactam; Oxacillin | 1980 |
Therapeutic approaches to anaerobic infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cefoxitin; Cephamycins; Chloramphenicol; Clindamycin; Drug Combinations; Female; Gastrointestinal Diseases; Genital Diseases, Female; Gram-Negative Anaerobic Bacteria; Humans; Male; Moxalactam; Respiratory Tract Infections; Skin Diseases, Infectious; Suppuration; Ticarcillin | 1981 |
Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy.
Topics: Adolescent; Adult; Cefoxitin; Clindamycin; Drug Resistance, Microbial; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Moxalactam; Vagina; Vaginitis; Vancomycin; Vibrio; Vibrio Infections | 1983 |
Periapical abscesses: causal bacteria and antibiotic sensitivity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxalactam; Pefloxacin; Periapical Abscess | 1997 |